No Detail Found!

Evaluation of nephrotoxicity by aspirin-clopidogrel combination therapy in patients with acute coronary syndrome.

Author(s)
Muhammad Imran Qadir Faculty of Pharmaceutical Sciences, Government College University, Faisalabad, Pakistan; Institute of Molecular Biology and Biotechnology, Bahauddin Zakariya University, Multan, Pakistan
Atta Ur Rehman Faculty of Pharmaceutical Sciences, Government College University,Faisalabad,Pakistan
Muhammad Sajid Hamid Akash Faculty of Pharmaceutical Sciences, Government College University,Faisalabad,Pakistan
Muhammad Irfan Faculty of Pharmaceutical Sciences, Government College University,Faisalabad,Pakistan
Muhammad Baber Institute of Molecular Biology and Biotechnology, Bahauddin Zakariya University,Multan,Pakistan
Syed Bilal Hussain Institute of Molecular Biology and Biotechnology, Bahauddin Zakariya University,Multan,Pakistan
Abstract
Although aspirin-clopidogrel combination is more useful for acute coronary syndrome (ACS), the renal safety of this combination had not been established. A total 60 patients with ACS were divided into three groups; receiving aspirin, clopidogrel and aspirin-clopidogrel combination. For determination of renal function, serum BUN, creatinine, uric acid, uric acid clearance and GFR were estimated for four months. The study showed that there were no significant (p>0.05) variations in the parameters when used the drugs in combination (aspirin-clopidogrel) compared with the drugs given alone.
Publication Details
Page(s) 2103-2104
DOI DOI not available
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 29, Issue: 6, Year: 2016

Request the full text from PASTIC

Keywords
Renal Function, Aspirin-clopidogrel combination
0

Citations

0

Downloads

90

Views